Asia Fresh News

Asia Fresh Stories

Archive for September 1st, 2015

OIA Global and Ditto Sustainable Brand Solutions Launch a Breakthrough Retail and Sustainability Logistics Program

leave a comment »

PORTLAND, Ore. /PRNewswire/ — OIA Global, a provider of worldwide logistics, packaging, and materials sourcing and Ditto Sustainable Brand Solutions, a green product design company, have announced a joint marketing agreement creating an innovative program for shipping and retailing called Garments on Ditto. This breakthrough is engineered to make shipping on hangers, commonly known as “Garments on Hanger” (GOH) far more efficient and will allow retailers to replace the billions of one-use, virgin plastic hangers now going into landfills every year. Steve Akre, OIA’s EVP of Business Development said “retailers can reduce shipping and warehousing costs up to 20% and achieve significant sustainability advances using the Garments on Ditto program.”

Logo –

The key component to the program is the Ditto hanger, made from 100% recycled paper fiberboard. The hanger is extremely durable and has marketing and retail benefits not possible with plastic hangers. Gary Barker, Ditto’s founder and CEO noted, “People think plastic store hangers are used repeatedly but once the garment is sold, there’s no reuse.” Studies show that 85% of retail plastic hangers are thrown out resulting in a staggering 34 billion hangers going into landfills annually. “With the single use plastic hanger actually costing almost 10 centsmore per garment to ship, sell, and dispose of, retailers are paying a premium to send tons of plastic to our landfills,” Barker noted.

The Ditto and OIA “Garments on Ditto” program launches on September 1st.

About OIA Global: Since its founding in 1988, OIA has grown into a $1 billion supply chain leader delivering clients a unique combination of global logistics, materials sourcing, and packaging solutions. With over 1000 professionals, in 60+ owned offices and a worldwide presence in over 25 countries, OIA designs innovative solutions that optimize supply chains around the world. OIA is a part of Indianapolis-based LDI, Ltd., a family office with more than a century of experience funding and operating high-potential, middle-market companies. For more information please visit and Contact Jerry Levy, Director of Marketing & Communications, OIA Global 503.736.5900

About Ditto: Ditto Brand Solutions, Oakland, CA conceives, engineers and produces highly-designed, sustainable retail displays. The Ditto Ecological Display is known the world over for its efficiencies, strength, beauty, and marketing power. For more information, please visit Contact Gary Barker, CEO, Ditto Sustainable Brand Solutions, +1-510-261-7343

Source: OIA Global

Written by asiafreshnews

September 1, 2015 at 5:01 pm

Posted in Uncategorized

Volkswagen Launches Cultural Engagement Initiative in China With Opening of the Rain Room Exhibition in Shanghai

leave a comment »

SHANGHAI and WOLFSBURG, Germany /PRNewswire/ —

  • Premiere in Asia: Together, Volkswagen Group China and YUZ Museum bring Rain Room to Shanghai
  • The largest installation to date of the artwork by Random International
  • Opening with around 300 guests from the fields of culture, economics and politics

– Cross reference: Picture is available at AP Images ( and  –

Volkswagen begins its activities as a cultural partner in China with the involvement of Volkswagen Group China in the Rain Room exhibition. Opened on Saturday evening in Shanghai, the exhibition marks the first display of Rain Room in China. The artwork created by the British-German artist collective, Random International, has already been met with great interest with displays in London and New York and for the first time occupies an area of 150m² in Shanghai so that it surpasses all previously exhibited versions.

(Photo: )
(Photo: )

Speaking to 300 invited guests, Budi Tek, founder of the YUZ foundation which operates the YUZ museum, andKlaus Biesenbach, Chief Curator at Large at the Museum of Modern Art (MoMA), New York and Director of MoMA PS1, who, together with Hans-Ulrich Obrist, was responsible for exhibition of Rain Room in New York, as well as Prof. Dr Jochem Heizmann, President and CEO of Volkswagen Group China and member of the Executive Board of Volkswagen AG, underlined the role of the exhibition for the creative dialogue.

With the support of the exhibition, Volkswagen is making an important contribution to the construction of new bridges between Western and Asian art. In this way, Volkswagen is linking its activities in China to collaboration with its other international partners. Since 2011, there has been a close partnership between Volkswagen Group of America and MoMA as well as MoMA PS1. Additionally, Volkswagen Group has maintained a partnership with the Nationalgalerie-Staatliche Museen zu Berlin since 2013.

Prof. Dr Jochem Heizmann said at the opening: “Art and culture are the driving force behind innovation, because often it is above all artists who manage to ask questions which awaken the urge for new discoveries. Volkswagen therefore promotes interaction with creative work with the greatest conviction. By supporting this exhibition, we will provide the starting signal to establish a creative platform which offers people new inspiration and provides an interesting perspective on the significance of environmental sustainability.”

With Rain Room, the artist group Random International has created an installation which combines technology and creative interaction in a unique way.  Rain Room is a room in which it is constantly raining. As soon as people move inside the room, however, the rain is interrupted precisely at these points. This makes highly-developed digital control possible which provides an unexpected refuge for the visitor in the middle of torrential rain. Rain Room was first displayed in London and subsequently in the New York Museum of Modern Art (MoMA). At the arrangement of Volkswagen, the idea matured to give the Chinese public the opportunity to experience this work. This idea was finally implemented together with the YUZ Foundation.

The YUZ Museum Shanghai exhibits Rain Room from 1 September to 31 December 2015 within the framework of a project partnership with Volkswagen Group China. The exhibition is supplemented with artistic learning opportunities for different ages which were also developed by YUZ Museum with the support of Volkswagen Group China. Volkswagen Group China will additionally invite Chinese users to reflect individually on the topic of water using various online channels in order to connect awareness of art and the environment.

Notes for editors:

Volkswagen Group China

Volkswagen employees around 91,000 staff in China and currently produces models for the Group trademarks Volkswagen Pkw, Audi, and SKODA for the Chinese market in the SVW and FAW-VW joint ventures at 20 locations. The vehicle production includes the local provision of engine and vehicle components.

This press release and accompanying image material can be found at


Volkswagen Group Communications
Head of Cultural Engagement
Benita von Maltzahn
Telephone: +49(0)5361/9-89-31-8
Fax: +49(0)5361/9-57-89-31-8

Spokesperson Cultural Engagement
Rita Werneyer
Telephone: +49(0)5361/9-79-86-4
Fax: +49(0)5361/9-56-85-22-2

Volkswagen Group China
Larissa Braun
Telephone: +86-10-6531-5482

Source: VW Volkswagen AG

Written by asiafreshnews

September 1, 2015 at 4:50 pm

Posted in Uncategorized

Bring the Entire Family with the Dusit Thani Krabi Beach Resort’s ‘Family Getaway Privilege’

leave a comment »

BANGKOK /PRNewswire/ — The recently rebranded Dusit Thani Krabi Beach Resort is quickly gaining iconic status as the region’s ultimate family playground. Building on the massive success of its grand opening, the resort introduces the Family Getaway Privilege package, “the” ticket to endless tropical family fun.

Bring the entire family with the Dusit Thani Krabi Beach Resort's 'Family Getaway Privilege'
Bring the entire family with the Dusit Thani Krabi Beach Resort’s ‘Family Getaway Privilege’

For a limited time, families can enjoy amazing upgrades and room specials along with tailor-made perks for children. Families receive 50% off when booking a connecting room for kids or a complimentary upgrade to a suite, inclusive of rollaway beds or cots if needed.

Children under 12 also receive free admission to Kid’s Club facilities and unlimited poolside beverages such as fruit juices or soft drinks. Daily breakfast is also included for two adults and two children under 12.

“I have been blown away by the overwhelming response to our newly rebranded resort,” said Mr. Urs Lienhard, General Manager of the Dusit Thani Krabi Beach Resort. “A broad cross section of travellers have descended on the resort, all praising the resort’s stunning surroundings, village-like atmosphere, fantastic amenities and first-class service.”

Visitors to international travel sites TripAdvisor was quick to respond to the Dusit Thani rebranding, immediately bestowing the resort with positive feedback that allowed it to debut with an 8.6 satisfaction ranking and an 8th place position on the respective sites.

About the new Family Getaway Privilege, Mr. Lienhard also noted, “Our goal is to open the doors of the Dusit Thani Krabi Beach Resort to let families create lifetime memories with a great package that caters specifically to their needs.”

Enjoy the “Beauty of Being Thai” and bring the whole family to discover the Dusit Thani Krabi Beach Resort with the limited-time Family Getaway Privilege package. For reservations and more information, please

For Media Contact & Fam Trip:

Ms. Somharuethai Donluem
Marketing Communications Manager
T: +66(0)2620 9889

Dusit Thani Krabi Beach Resort:
155 Moo 2,
Nong Thale,
Muang Krabi,
Krabi 81180
Tel. +66(0)75 628 000
Fax. +66(0)75 628 028

Photo –

Source: Dusit Thani Krabi Beach Resort

Written by asiafreshnews

September 1, 2015 at 4:41 pm

Posted in Uncategorized

Atos Delivers The Extraordinary at The 28Th South East Asian Games Singapore 2015

leave a comment »

-Games Management System implemented across 31 venues and 402 events

SINGAPORE /PRNewswire/ —Atos, an international leader in digital services, today announced that as the appointed Official IT Integration Partner, it delivered its integration expertise on an extraordinary scale at the 28th South East Asian Games Singapore 2015 (SEA Games 2015).

Its 270 member strong, multi-national project team from China, Spain and Singapore helped define new standards for future SEA Games and Major Events across the world.

Amidst critical deadlines, requirement changes and sheer scale of event, Atos achieved its own Gold standard in the race against time, resource and cost. The dedicated team of business technologists implemented an improved Games Management System across 31 venues and 402 events. This ensured an efficient flow of IT processes and support for the Games preventing any outage throughout the duration of the Games.

Additionally a dedicated mobile application was launched, a first for the SEA Games, bringing the latest games results to the public enhancing public engagement and accessibility to the Games itself.

“The South East Asian Games could not have been staged without the right technology behind them. With our vast experience, we take advantage of the latest advances in technology. We have helped to transform the IT of these Games, improving the experience for athletes, spectators and viewers. Atos embraces digital transformation and see step changes in how disruptive technologies address emerging challenges and make a major impact,” saysMarta Sanfeliu, General Manager Olympics, Major Events at Atos.

“Our personal conviction to deliver a flawless performance through cost effective measures, robust and secure platforms thereby developing new documentations and tools has set a new benchmark in the Major Events industry. I am proud of our achievements. More so of our team that has once again proven their mettle,” saysHerbie Leung, APAC CEO, Atos.

Atos achievements SEAG 2015
Atos achievements SEAG 2015

About Atos

Atos SE (Societas Europaea) is a leader in digital services with 2014 pro forma annual revenue of circa  EUR11 billion and 93,000 employees in 72 countries. Serving a global client base, the Group provides Consulting & Systems Integration services, Managed Services & BPO, Cloud operations, Big Data & Cyber-security solutions, as well as transactional services through Worldline, the European leader in the payments and transactional services industry. With its deep technology expertise and industry knowledge, the Group works with clients across different business sectors: Defense, Financial Services, Health, Manufacturing, Media, Utilities, Public sector, Retail, Telecommunications, and Transportation.

Atos is focused on business technology that powers progress and helps organizations to create their firm of the future. The Group is the Worldwide Information Technology Partner for the Olympic & Paralympic Games and is listed on the Euronext Paris market. Atos operates under the brands Atos, Atos Consulting, Atos Worldgrid, Bull, Canopy, and Worldline. For more information, visit:

Media contact:

Rhoda Dinesen
M: +65-9168-1146

Photo –

Source: Atos Information Technology
Related Links:

Written by asiafreshnews

September 1, 2015 at 4:15 pm

Posted in Uncategorized

Novogen Announces The Outcome Of A Comprehensive Science Review

leave a comment »

— Novogen will focus the development programs for each of our three lead candidates to achieve the earliest possible initiation of clinical studies. We affirm our goal to have two products enter clinical development in 2016
— Specific indications, formulations and routes of administration have been confirmed for each program with emphasis on achieving robust data-driven milestones required to meet pre-clinical and clinical regulatory‎ requirement
— The Company’s extensive medicinal chemistry expertise and compound library coupled with its ongoing collaborations with Yale University and the University of NSW enables us to further strengthen, protect and target our future discovery programs and our intellectual property estate
— Further management and staff appointments have been made to strengthen in-house capabilities in terms of manufacturing, project management, intellectual property and investor relations expertise
— High quality candidates have been identified for the permanent CEO position including some from overseas. Interviewing of final short-listed candidates will commence mid-October with view to announcing an appointment by year-end. Recruitment of a CMO (Chief Medical Officer) is ongoing
— The Company is in a strong financial position to support the progression of the lead programs through to the clinic

SYDNEY /PRNewswire/ — US-Australian drug discovery company, Novogen Limited (ASX: NRT; NASDAQ: NVGN) today confirmed its comprehensive scientific review has identified high value opportunities for its ground-breaking technology platforms in areas of unmet patient need. Novogen is moving as quickly as practicable through the remaining preclinical projects prior to entering into Phase 1 clinical trials with our 3 lead compounds.

Acting Chief Executive Officer, Iain Ross, said that following his appointment last month, Novogen initiated a company-wide review, including a comprehensive science review, to determine top priorities and enabling the Company to focus valuable resources to achieve high value opportunities in a highly competitive market place.

“In keeping with industry best practice and Novogen’s commitment to maintaining a high standard of scientific integrity, we’ve formed a Scientific Review Committee to ensure rigor is applied to all of our decision-making processes. Committee members include retired Executive Vice President for Eli Lilly & Co and President of Lilly Bio-Medicines, Bryce Carmine, as well as two eminent academic researchers: Professor Peter Gunning  from theUniversity of New South Wales, Australia, and Professor Gil Mor from Yale University in the USA.”

“I am delighted to report our Scientific Review Committee has identified realistic opportunities based on the extensive data available for our lead drug candidates. We have therefore chosen to tighten our focus on significant areas of unmet patient need. Given scientific success we are confident these opportunities will enable us to drive strong value for shareholders,” Mr Ross said.

“The Company is in a strong financial position to expeditiously drive our three drug candidates through their final requisite pre-clinical safety programs and ultimately into Phase 1 clinical trials. This will be our next critical decision point. In line with our business strategy, we will be applying our resources to target opportunities that could generate the greatest return.”

“Pending the outcome of the required safety studies we are committed to progressing Cantrixil and Anisina to Phase 1 clinical trials in 2016 and Trilexium by 2017. We will be continuing to work through the necessary regulatory requirements as thoroughly and as quickly as practicable,” Mr Ross said.

“Another significant outcome of our scientific review has been the recognition of the depth of our medicinal chemistry expertise across our two technology platforms. This secures for the Company exceptional future growth opportunities, provides back-ups for our existing lead compounds and opens up new avenues for future discovery. Our actions have also strengthened our existing patent protection.”

Mr Ross said that following the scientific review, the Company had decided to pursue a patent protection approach for its degenerative and regenerative medicine program known as Jacob’s Hope. This program would now take a lower profile while we focus on the nearer term core opportunities.



Cantrixil is the Company’s lead superbenzopyran (SBP) drug candidate designed to be injected into the intra-peritoneal (IP) cavity. We aim to treat ovarian cancer by targeting both differentiated cancer cells and potentially cancer initiating cells, the cells thought to be responsible for cancer recurrence post chemotherapy.

Therefore, Novogen is continuing to progress Cantrixil through its safety evaluation program and fulfil the necessary regulatory requirements with a view to starting Phase 1 clinical trials in 2016. As Cantrixil is a cytotoxic drug, safety signals have been identified in the cardiovascular and gastrointestinal systems that require further evaluation. It is important to note that the standard treatment for ovarian cancer patients has not significantly changed over the past 30 years and their prognosis remains exceptionally poor with as many as 80% of these patients suffering a relapse and ultimately an early death. Therefore an urgent unmet clinical need remains for all ovarian cancer patients. The Cantrixil preliminary safety observations have been discussed with the Medical Study Committee who concur that the benefits to ovarian cancer patients may significantly outweigh the associated risks while on treatment.

Novogen will inform shareholders once these evaluations have been completed. Assuming success the Company will progress to clinical trial in Australia focussing on late-stage ovarian cancer patients who may or may not have associated malignant ascites using an intraperitoneal mode of delivery.

While it is not possible at this stage to be precise as to when clinical trials will commence, the Company continues to target 2016 to commence a first-in-human trial for Cantrixil in Australia.


Anisina is the Company’s lead anti-tropomyosin (ATM) compound, which is a unique first-in-class anti-cancer agent. This small ATM molecule targets a core protein component of the actin microfilaments, tropomyosin Tpm3.1, essential for tumor cell survival.

The pre-clinical evidence available supports the entry of Anisina into the regulatory required safety evaluation program. While this program is progressing, the Company will continue to evaluate the potential lead adult cancer indications to target in the clinic. This evaluation will guide us towards decisions that support a pediatric neuroblastoma program for Anisina where it has been shown to enhance the efficacy of anti-microtubule agents when assessed in pre-clinical models of human pediatric neuroblastoma.

Pending a successful safety evaluation outcome, the Company is targeting 2016 to open an all-comers Phase 1 clinical trial in Australia, where the primary outcome will be safety. Novogen has re-affirmed our commitment to pediatric neuroblastoma and has assembled the relevant therapeutic medical experts to participate on an Anisina pediatric oncology board.

Trilexium (TRXE-009)

TRXE-009 is the Company’s second lead SBP drug candidate and our least advanced drug candidate. The Company has identified a high value opportunity where there are currently no approved treatments and the current life-expectancy for patients is no more than 8 months.

Through our collaboration with a local pediatric medical oncologist, the Company has confirmed that Trilexium is exquisitely active against patient derived explants of Diffuse Intrinsic Pontine Glioma (DIPG) in pre-clinical studies. DIPG is an aggressive but rare brain tumor primarily affecting children. Novogen has identified a drug formulation that in animals is able to deliver Trilexium to brain tissue and researchers will soon commence a proof-of-concept pre-clinical study in an orthotropic model of DIPG.

Once this proof-of-concept study is completed, the Company plans to commence the required safety evaluation program. By targeting DIPG, the Company anticipates that this strategy may provide a fast-to-market opportunity and is also planning to file for an Orphan Drug Designation status with the FDA. At this stage, first-in-human trials are targeted to commence by 2017.

About Novogen

Novogen is a public, Australian-US drug development company whose shares trade on both The Australian Securities Exchange (NRT) and NASDAQ (NVGN). The Novogen group includes US-based, CanTx Inc., a joint venture company with Yale University. Novogen has two drug technology platforms [the superbenzopyrans (SBPs) and anti-tropomyosins (ATMs)] yielding drug candidates that are first-in-class with potential application across a range of degenerative diseases. Given the encouraging data from in vitro and in vivo pre-clinical proof-of-concept studies in the field of oncology, our immediate focus is to undertake their respective toxicology programs. Our target indication for Cantrixil is ovarian cancer, and Diffuse Intrinsic Pontine Glioma (DIPG) for Trilexium. While the initial target pediatric indication for Anisina has been identified as neuroblastoma, we are yet to identify the adult indication and are intending to open an all-comers Phase I trial initially based on our pre-clinical studies. For more information, please visit

Forward Looking Statement

This press release contains “forward-looking statements” within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934. The Company has tried to identify such forward-looking statements by use of such words as “expects,” “appear,” “intends,” “hopes,” “anticipates,” “believes,” “could,” “should,” “would,” “may,” “target,” “evidences” and “estimates,” and other similar expressions, but these words are not the exclusive means of identifying such statements. Such statements include, but are not limited to any statements relating to the Company’s drug development program, including, but not limited to the initiation, progress and outcomes of clinical trials of the Company’s drug development program, including, but not limited to, Cantrixil, Anisina, Trilexium, and any other statements that are not historical facts. Such statements involve risks and uncertainties, including, but not limited to, those risks and uncertainties relating to the difficulties or delays in financing, development, testing, regulatory approval, production and marketing of the Company’s drug components, including, but not limited to, Cantrixil, Anisina, Trilexium, the ability of the Company to procure additional future sources of financing, unexpected adverse side effects or inadequate therapeutic efficacy of the Company’s drug compounds, including, but not limited to, Cantrixil, Anisina, Trilexium, that could slow or prevent products coming to market, the uncertainty of patent protection for the Company’s intellectual property or trade secrets, including, but not limited to, the intellectual property relating to Cantrixil, Anisina, Trilexium, and other risks detailed from time to time in the filings the Company makes with Securities and Exchange Commission including its annual reports on Form 20-F and its reports on Form 6-K. Such statements are based on management’s current expectations, but actual results may differ materially due to various factions including those risks and uncertainties mentioned or referred to in this press release. Accordingly, you should not rely on those forward-looking statements as a prediction of actual future results.

Source: Novogen Ltd
Related Links:

Written by asiafreshnews

September 1, 2015 at 3:35 pm

Posted in Uncategorized Study Reveals Travelers’ Prefer Free Wi-Fi to Free Breakfast

leave a comment »

SINGAPORE /PRNewswire/ —, one of the world’s leading accommodation sites and part of Nasdaq-listed Priceline Group (Nasdaq:PCLN), announced today the results of its most recent Travel Smartssurvey, which shows travelers prefer free in-room Wi-Fi to free breakfast.

According to an study, travelers prefer free Wi-Fi over free breakfast and a bigger bed over a bigger bathroom.
According to an study, travelers prefer free Wi-Fi over free breakfast and a bigger bed over a bigger bathroom.

The survey, conducted in July 2015, asked over 5,000 customers from around the world which amenities they want in hotel rooms.

When asked which they’d rather have for free, travelers prefer Wi-Fi over breakfast, but barely. Wi-Fi got 55% of the vote and breakfast 45%.

“We know both are important to our customers,” says John Brown,’s Chief Operating Officer. “Most hoteliers understand that, too, and the majority of the properties on offer room rates inclusive of Wi-Fi, breakfast or both,” he said.

Travelers do have a clear preference when it comes to spacious beds, though. When asked whether they’d prefer a bigger bed or a bigger bathroom, 75% picked a bigger bed.

About Agoda Company Pte Ltd:

Agoda Company Pte Ltd ( is a leading Asia-based, online accommodation reservations company, which specializes in securing the lowest discount accommodation prices. is part of The Priceline Group (Nasdaq:PCLN).’s network includes more than 700,000 hotels and other accommodation properties worldwide. The multinational staff of more than 1,700 professionals, located throughout the world, provides a first-rate reservation service that uniquely combines local knowledge and local connections to provide the best accommodation deals to both business and leisure travelers.

A member of the Pacific Asia Travel Association (PATA),’s aim is to promote travel by making it moreaffordable and more accessible to more people. AGODA® is a registered trademark of AGIP LLC, used under license by Agoda Company Pte. Ltd.

For more information about the study, please contact Nico Marco, public relations leader,

To connect with and learn about special deals and promotions on hotels worldwide, like us on Facebookor follow us on Google+, Instagram, or Pinterest.

Photo –

Source: Agoda Company Pte Ltd

Related stocks: NASDAQ-NMS:PCLN

Related Links:

Written by asiafreshnews

September 1, 2015 at 3:19 pm

Posted in Uncategorized

IIC Opens in Shenzhen Today with New Technologies from Top Semiconductor Companies

leave a comment »

SHENZHEN /PRNewswire/ — IIC Fall 2015 opens today inShenzhen, the hub for electronics innovation in South China, and will run through toSeptember 3. Targeting electronics engineers, the event features an exhibition and more than 40 technical presentations on the Internet of Things, smart home, smart devices, Bluetooth, automotive electronics and power technologies. Exhibitors and speakers come from leading global companies such as Allegro, Atmel, Infineon, Keysight, Linear, Mouser, R&S and Qualcomm, as well as top Chinese IC companies including DIOO, SG Micro and VeriSilicon.

Brandon Smith, President of eMedia Asia, said: “Innovation has never been more important for local electronics companies’ survival. Here, design engineers can find new ideas and technologies that will lead to amazing future products. We have also invited some inventive ‘makers’ to show their design and share with fellow engineers. Their energy and passion for innovation is truly contagious.”

In keeping with its focus on serving the engineering community, IIC is teaming up with the IEEE Microwave Theory and Techniques Society (MTT-S) to launch Tech Shanghai in March 2016, which brings together the latest microwave and semiconductor technologies that will make the world ever more connected.

For more information on IIC, please visit

About eMedia Asia

eMedia Asia, a wholly-owned subsidiary company of UBM plc, provides 500,000-plus technology decision-makers throughout Asia and China with access to a multichannel media network. Through its technical events, publications and online network, eMedia Asia leads in providing the region’s electronics community with the business and technical information they need to remain competitive.

Press Contact

Ronny Pang

Tel: (852) 2831 0253



Logo –
Logo –

Source: eMedia Asia

Written by asiafreshnews

September 1, 2015 at 3:16 pm

Posted in Uncategorized